GlassScriptPhysician profile
Nathan Mickinac
NPI 1679078422
$1,487.38
in general payments reported to CMS, 2019-2025
8 companies · $823 in 2025
The $823 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $81.99 · 2023: $301 · 2024: $281 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $364.71 | 2024-2025 | 2d Helical - 35, Therasphere Y90 Glass Microspheres 10 Gbq, Complex Helical - 18 |
| Sirtex Medical INC | $317.43 | 2023-2025 | Sir-Spheres Microspheres |
| Penumbra, INC. | $231.81 | 2025 | Indigo System |
| Inari Medical, INC. | $227.72 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $181.90 | 2025 | Abre, Synchromedii |
| Terumo Medical Corporation | $119.95 | 2022-2025 | Tr Band, Glidesheath Slender |
| Cardiva Medical, INC. | $25.10 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Argon Medical Devices, INC. | $18.76 | 2024 | Clot Management |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Mickinac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.